Caricamento...
New Oral Anticoagulants in Nonvalvular Atrial Fibrillation
The choice of an oral anticoagulant (OAC) for patients with nonvalvular atrial fibrillation (NVAF) is a major and complex clinical decision taking into account the individual risk‐benefit ratio and bearing in mind the chronicity of therapy. This review focuses on the safety and efficacy of new oral...
Salvato in:
| Pubblicato in: | Clin Cardiol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley Periodicals, Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6490750/ https://ncbi.nlm.nih.gov/pubmed/27716952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22582 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|